PPARG and polycystic ovary syndrome: In addition, paeoniflorin (89) and astragaloside IV (51) lowered serum LH concentrations in DHEA-induced PCOS rats by modulating the TGF-β1/Smads and PPARγ signaling pathway, promoting ovarian health and regulating the reproductive cycle.